Medcaw Investments (MCI) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock MCI vs. MNTC, SEED, ALGW, D467, WSL, CMB, BRH, CCPE, OTT, and NCAShould you be buying Medcaw Investments stock or one of its competitors? The main competitors of Medcaw Investments include The Schiehallion Fund (MNTC), Seed Innovations (SEED), Alpha Growth (ALGW), Thames Ventures VCT 2 DP67 (D467), Worldsec (WSL), Cambria Africa (CMB), Braveheart Investment Group (BRH), CVC Credit Partners European Opportunities (CCPE), Oxford Technology 3 Venture Capital Trust (OTT), and New Century AIM VCT (NCA). These companies are all part of the "asset management" industry. Medcaw Investments vs. The Schiehallion Fund Seed Innovations Alpha Growth Thames Ventures VCT 2 DP67 Worldsec Cambria Africa Braveheart Investment Group CVC Credit Partners European Opportunities Oxford Technology 3 Venture Capital Trust New Century AIM VCT Medcaw Investments (LON:MCI) and The Schiehallion Fund (LON:MNTC) are both small-cap financial services companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, community ranking, risk, analyst recommendations, media sentiment, earnings and profitability. Does the media refer more to MCI or MNTC? In the previous week, Medcaw Investments had 1 more articles in the media than The Schiehallion Fund. MarketBeat recorded 1 mentions for Medcaw Investments and 0 mentions for The Schiehallion Fund. Medcaw Investments' average media sentiment score of 1.08 beat The Schiehallion Fund's score of 0.00 indicating that Medcaw Investments is being referred to more favorably in the media. Company Overall Sentiment Medcaw Investments Positive The Schiehallion Fund Neutral Which has better earnings & valuation, MCI or MNTC? Medcaw Investments has higher revenue and earnings than The Schiehallion Fund. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedcaw InvestmentsN/AN/AN/A-£0.04N/AThe Schiehallion Fund-£256.11M0.00-£267.21M£0.09N/A Do insiders and institutionals hold more shares of MCI or MNTC? 24.2% of The Schiehallion Fund shares are owned by institutional investors. 27.5% of Medcaw Investments shares are owned by company insiders. Comparatively, 0.1% of The Schiehallion Fund shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is MCI or MNTC more profitable? The Schiehallion Fund's return on equity of -19.31% beat Medcaw Investments' return on equity.Company Net Margins Return on Equity Return on Assets Medcaw InvestmentsN/A -51.13% -10.82% The Schiehallion Fund N/A -19.31%-12.03% Does the MarketBeat Community prefer MCI or MNTC? Medcaw Investments and The Schiehallion Fund both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformMedcaw InvestmentsN/AN/AThe Schiehallion FundN/AN/A SummaryMedcaw Investments beats The Schiehallion Fund on 5 of the 9 factors compared between the two stocks. Get Medcaw Investments News Delivered to You Automatically Sign up to receive the latest news and ratings for MCI and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MCI vs. The Competition Export to ExcelMetricMedcaw InvestmentsAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£775,000.00£1.13B£3.89B£2.64BDividend YieldN/A4.38%4.16%4.81%P/E Ratio-87.5020.7112.81134.69Price / SalesN/A2,313.011,712.66243,619.17Price / CashN/A61.2550.5128.38Price / BookN/A1.133.434.53Net IncomeN/A£264.31M£1.18B£5.91B Medcaw Investments Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MCIMedcaw InvestmentsN/AN/AN/AN/A£775,000.00N/A-87.503Earnings ReportPositive NewsGap DownHigh Trading VolumeMNTCThe Schiehallion FundN/AN/AN/AN/A£3.08M£-256,110,000.004.89N/AGap DownSEEDSeed InnovationsN/AGBX 1.50-6.2%N/AN/A£2.95M£-487,033.83-2.0552Gap DownALGWAlpha GrowthN/AGBX 0.60+4.6%N/A-67.8%£2.87M£4.16M-1.844D467Thames Ventures VCT 2 DP67N/AN/AN/AN/A£2.69MN/A-1,200.00N/AGap DownWSLWorldsecN/AGBX 2.45+22.5%N/AN/A£2.61M£-270,215.86-3.24N/ACMBCambria AfricaN/AN/AN/AN/A£2.45M£1.41M-3.759BRHBraveheart Investment GroupN/AGBX 3.80-5.0%N/A-45.0%£2.42M£1.24M-0.375News CoverageGap DownCCPECVC Credit Partners European OpportunitiesN/AN/AN/AN/A£2.13MN/A0.00N/AGap DownOTTOxford Technology 3 Venture Capital TrustN/AN/AN/AN/A£2.13M£-85,000.00-12.59203Gap DownNCANew Century AIM VCTN/AN/AN/AN/A£2.00M£-2,760,000.00-68.92N/A Related Companies and Tools Related Companies The Schiehallion Fund Alternatives Seed Innovations Alternatives Alpha Growth Alternatives Thames Ventures VCT 2 DP67 Alternatives Worldsec Alternatives Cambria Africa Alternatives Braveheart Investment Group Alternatives CVC Credit Partners European Opportunities Alternatives Oxford Technology 3 Venture Capital Trust Alternatives New Century AIM VCT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:MCI) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medcaw Investments Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Medcaw Investments With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.